Optimization of MammoSite therapy

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 1, 2004, Pages 220-232

  Astrahan, Melvin A ^a,b   Jozsef, Gabor ^a   Streeter Jr , Oscar E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Brachytherapy; Breast cancer; Dosimetry; High dose rate; Radiation

Indexed keywords

ANISOTROPY; BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; OPTIMIZATION; RADIOTHERAPY; SKIN;

BRACHYTHERAPY;

ONCOLOGY;

ANISOTROPY; ARTICLE; BRACHYTHERAPY; CATHETER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEVICE; DOSIMETRY; DRUG MEGADOSE; HEALTH CARE PLANNING; HUMAN; MAMMOSITE THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIOTHERAPY;

EID: 0347624516     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)01458-5     Document Type: Article

References (12)

1. Gage I., Recht A., Gelman R., et al. Long-term outcome following breast conserving surgery, and radiation therapy. Int J Radiat Oncol Biol Phys. 33:1995;245-251.
2. Jozsef G., Luxton G., Formenti S.C. Application of radiosurgery principles to a target in the breast A dosimetric study . Med Phys. 27:2000;1005-1010.
3. Formenti S.C., Rosenstein B., Skinner K.A., et al. T1 stage breast cancer Adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients - Pilot feasibility study . Radiology. 222:2002;171-178.
4. Baglan K.L., Martinez A.A., Frazier R.C., et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 50:2001;1003-1011.
5. Wazer D.E., Berle L., Graham R., et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 53:2002;889-897.
6. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 55:2003;289-293.
7. Edmundson G.K., Vicini F.A., Chen P.Y., et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 52:2002;1132-1139.
8. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 . Med Phys. 24:1995;209-234.
9. Astrahan M., Streeter O., Jozsef G. Calculation of mean central dose in interstitial brachytherapy using Delaunay triangulation. Med Phys. 28:2002;1016-1023.
10. Jozsef G, Streeter O, Astrahan M. Linear optimization of HDR brachytherapy. Med Phys 2003;30:751-760.
11. Papagiannis P., Angelopoulos A., Pantelis E., et al. Dosimetry comparison of Ir-192 sources. Med Phys. 29:2002;2239-2246.
12. Wazer D.E., Lowther D., Boyle T., et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 50:2001;107-111.